Hyperleukocytosis Management

Primary Causes and Complications

Hyperleukocytosis, characterized by a white blood cell count greater than 100,000/μL, is most commonly caused by acute leukemia and requires immediate medical attention due to the risk of leukostasis, which can lead to life-threatening complications including hemorrhagic events, tumor lysis syndrome, and infections, as stated by the American Society of Hematology 1
Severe sepsis may present with marked leukocytosis, though more commonly with counts below 100,000/μL, according to the Society of Critical Care Medicine 2
Tumor lysis syndrome results from rapid breakdown of malignant cells, causing metabolic derangements, and can lead to acute kidney injury and cardiac arrhythmias, as noted by the National Comprehensive Cancer Network 3
Hyperleukocytosis can trigger coagulation abnormalities and bleeding diathesis, and may present with thrombocytopenia and abnormal coagulation studies, as reported by the American Society of Hematology 1

Aggressive intravenous hydration (2.5-3 liters/m²/day) to maintain good urine output and reduce blood viscosity is recommended by the American Society of Clinical Oncology 3
Hydroxyurea (50-60 mg/kg/day) can be used to rapidly reduce white blood cell counts, as suggested by the European Society for Medical Oncology 1, 3
Prevention of tumor lysis syndrome with allopurinol or rasburicase is advised by the National Comprehensive Cancer Network 1, 3
Careful monitoring of fluid balance to avoid excessive red blood cell transfusions which can increase blood viscosity is recommended by the American Association of Blood Banks 1

Children with Down's syndrome and leukemia require specific protocols with reduced toxicity due to increased risk of complications, as noted by the International Society of Paediatric Oncology 4
Other laboratory tests should include complete metabolic panel, uric acid level, and coagulation studies, as recommended by the College of American Pathologists 3

Excessive fluid administration without careful monitoring can worsen pulmonary leukostasis, as warned by the American Thoracic Society 1
Failing to monitor for and prevent tumor lysis syndrome, which can rapidly lead to organ failure, is a critical mistake, as emphasized by the National Kidney Foundation 1, 3
Administering prophylactic platelet transfusions without clear indications can increase blood viscosity, as cautioned by the American Society of Hematology 1